Arteris, Inc. (AIP) Financial Statements
Arteris, Inc. (AIP) reported trailing twelve-month revenue of $84.6M (up 33.8% year on year) and net income of -$39.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $6.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AIPArteris, Inc.Follow AIP — free
—
Price chart with a free account
- Market cap
- 936.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Revenue | 37.9 | 50.4 | 53.7 | 57.7 | 70.6 | 84.6 | |
| Gross profit | 34.1 | 46.1 | 48.6 | 51.8 | 63.7 | 74.1 | |
| Research & development | 30.8 | 41.2 | 45.1 | 45.0 | 49.9 | 57.1 | |
| Operating income | -21.8 | -28.9 | -35.1 | -31.6 | -33.1 | -40.4 | |
| Pre-tax income | -22.3 | -27.8 | -35.2 | -31.1 | -33.3 | -42.2 | |
| Income tax | 1.0 | -0.4 | 1.7 | 2.5 | 1.5 | -2.6 | |
| Net income | -23.4 | -27.4 | -36.9 | -33.6 | -34.7 | -39.5 | |
| Diluted EPS ($) | -1.06 | -0.84 | -1.03 | -0.86 | -0.82 | -0.87 | |
| Diluted shares (mn) | 22.0 | 32.6 | 35.7 | 38.9 | 42.3 | — |
USD millions · SEC XBRL
Arteris, Inc. — questions
- What is Arteris, Inc.'s revenue?
- $84.6M over the twelve months to 2026-06-30, up 33.8% year on year, from its 10-Q and 10-K filings.
- What is Arteris, Inc.'s net income?
- -$39.5M over the twelve months to 2026-06-30.
- What is Arteris, Inc.'s free cash flow?
- $6.8M over the twelve months to 2026-06-30.
- What are Arteris, Inc.'s diluted earnings per share?
- $-0.87 over the twelve months to 2026-06-30.
Every figure on this page comes from Arteris, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.